Amicus Therapeutics

ISIN US03152W1099

 | 

WKN A0MSMZ

Market cap (in EUR)
1,660.14 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 1,660.14 m
EPS, EUR -0.09
P/B ratio 9.67
P/E ratio -
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 488.40 m
Net income, EUR -51.87 m
Profit margin -10.62%

What ETF is Amicus Therapeutics in?

There are 29 ETFs which contain Amicus Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Amicus Therapeutics is the WisdomTree BioRevolution UCITS ETF USD Acc.

Order fees

Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.
 
Broker Rating Order fee Stock savings plans
0.99€
1000
View offer*
1.00€
2500
View offer*
0.00€
2500
View offer*
0.00€
1200
View offer*
0.00€
500
View offer*
Show all offers
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
 
Broker Rating Execution fee Account fee
0.00€
0.00€
View offer*
0.00€
0.00€
View offer*
0.00€
0.00€
View offer*
1.50€
1.50%
0.00€
View offer*
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.